To find out more about Indexing services in which Annals of Intensive Care is included, see the 'About' page
Few specific medications have been proven effective for the treatment of patients with severe coronavirus disease 2019 (COVID-19). Here, Zhang et al. tested whether high-dose vitamin C infusion was effective for severe COVID-19.
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study
This is a bicenter retrospective study which took place in two intensive care units (ICU) of tertiary hospitals in the Paris region from March 11, to May 3, 2020. According to results, high flow nasal canula oxygen for acute respiratory failure (ARF) due to COVID-19 is associated with a lower rate of invasive mechanical ventilation.
Severe COVID-19 pediatric cases are less frequent than the adults ones, nevertheless acute myocarditis with intense systemic inflammation and atypical Kawasaki disease was reported as an emerging severe pediatric disease following SARS-CoV-2 infection. M. Grimaud et al. here provide the first characterization and assessment of this upcoming clinical post-infective complications of SARS-CoV-2 infection.Read More
Early recognition and intervention is crucial in the struggle against COVID-19 pandemics.
Quin Sun et al. retrospectively summarize the therapeutic process and figure out critical care-dominated treatment patterns that might be the core in reducing mortality.
Jean-Louis Teboul, CHU Bicêtre, Le Kremlin-Bicêtre, France
Aims and scope
We collect here the most recent research updates on SARS-CoV-2 management and treatment published in the journal to make them easily discoverable to the research community
Annual Journal Metrics
4 days to first decision for all manuscripts (Median)
36 days to first decision for reviewed manuscripts only (Median)
2,184,121 Downloads (2021)
5,706 Altmetric mentions (2021)
- ISSN: 2110-5820 (electronic)